Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 31 Advanced Solid Tumors 25 Advanced Solid Tumor 24 Carcinoma, Non-Small-Cell Lung 20 Neoplasms 15 Solid Tumor 12 Prostatic Neoplasms 12 Multiple Myeloma 12 Neoplasm Metastasis 11 Recurrence 10 Pancreatic Neoplasms 10 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Lung Neoplasms 9 Stomach Neoplasms 8 Melanoma 8 Lymphoma, Large B-Cell, Diffuse 8 Leukemia, Myeloid, Acute 8 Carcinoma, Hepatocellular 8 Triple Negative Breast Neoplasms 7 Sarcoma 7 Colorectal Neoplasms 7 Uterine Cervical Neoplasms 6 Solid Tumors 6 Carcinoma, Transitional Cell 5 Advanced Solid Tumour 5 Squamous Cell Carcinoma of Head and Neck 4 Nasopharyngeal Carcinoma 4 Myelodysplastic Syndromes 4 Lymphoma 4

Interventions

human papillomavirus vaccine, L1 type 16, 18 36 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 19 Papillomavirus Vaccines 16 Vaccines 10 Data Collection 9 Blood Specimen Collection 5 Vaccines, Synthetic 4 artesunic acid 3 artemisinin 3 Engerix-B 3 halofantrine 2 epigallocatechin gallate 2 artenimol 2 Hepatitis A Vaccines 2 GX-188 vaccine 2 Colposcopy 2 ranpirnase 1 fludarabine 1 Viusid 1 Vitamin B 12 1 VP-102 1 VGX-3100 1 Therapies, Investigational 1 Sodium Chloride 1 Pentetic Acid 1 Observation 1 Methods 1 Measles-Mumps-Rubella Vaccine 1 Interleukin-2 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Papillomavirus Infections × Injections × Clear all

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡